MENU
TRAX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

First Tracks Biotherapeutics (TRAX) Ownership - Who owns First Tracks Biotherapeutics?

First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.54B
P/E Ratio
N/A
Total Cash
286.46M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
8.02
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Who owns First Tracks Biotherapeutics? TRAX symbol Ownership - Tickeron.com